Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 15/20 | 0.53 |
| ▸ | PGR | P06401 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23916514 | 0.90 | AR (0.56) | ARPGRKDM4EALDH1A1USP2 | |
| SCHEMBL20299013 | 0.84 | KDM4E (0.66) | ARPGRKDM4EALDH1A1USP2 | |
| SCHEMBL20329652 | 0.80 | ALDH1A1 (0.60) | ARPGRKDM4EALDH1A1USP2 | |
| SCHEMBL23909977 | 0.79 | KDM4E (0.49) | ARPGRKDM4EALDH1A1USP2 | |
| SCHEMBL21071550 | 0.79 | KDM4E (0.62) | ARPGRKDM4EALDH1A1USP2 | |
| SCHEMBL20329375 | 0.78 | TSHR (0.41) | ARPGRALDH1A1GLAGAA | |
| SCHEMBL20329370 | 0.77 | KDM4E (0.60) | ARPGRKDM4EALDH1A1USP2 | |
| SCHEMBL23909968 | 0.77 | KIF11 (0.59) | ARPGRALDH1A1GLAGAA | |
| SCHEMBL20329162 | 0.77 | KDM4E (0.58) | ARPGRKDM4EALDH1A1USP2 | |
| SCHEMBL1013276 | 0.77 | GAA (0.50) | ARKDM4EALDH1A1USP2GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317092-A1 | TETRAZOLE CONTAINING COMPOUNDS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317092-A1 | TETRAZOLE CONTAINING COMPOUNDS | TSLP, IL5, TRPA1 | AR 3762/4885PGR 3832/4885KDM4E 4547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.